Heidelberg Pharma AG (ETR:HPHA)
3.060
-0.090 (-2.86%)
At close: Jan 23, 2026
Heidelberg Pharma AG Employees
Heidelberg Pharma AG had 114 employees as of August 31, 2025. The number of employees increased by 9 or 8.57% compared to the same quarter last year.
Employees
114
Change
9
Growth
8.57%
Revenue / Employee
€26,644
Profits / Employee
€229,629
Market Cap
143.15M
Employees Chart
Employees History
| Date | Employees | Change (1Y) | Growth (1Y) |
|---|---|---|---|
| Aug 31, 2025 | 114 | 9 | 8.57% |
| May 31, 2025 | 111 | 13 | 13.27% |
| Feb 28, 2025 | 105 | 7 | 7.14% |
| Nov 30, 2024 | 105 | 10 | 10.53% |
| Feb 29, 2024 | 98 | -2 | -2.00% |
| Nov 30, 2023 | 95 | -7 | -6.86% |
| Feb 28, 2023 | 100 | 11 | 12.36% |
| Nov 30, 2022 | 102 | 13 | 14.61% |
| May 31, 2022 | 93 | 6 | 6.90% |
| Feb 28, 2022 | 89 | 7 | 8.54% |
| Nov 30, 2021 | 89 | 11 | 14.10% |
| May 31, 2021 | 87 | 14 | 19.18% |
| Feb 28, 2021 | 82 | 10 | 13.89% |
| Nov 30, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| May 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Feb 29, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Nov 30, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| May 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Feb 28, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Nov 30, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| May 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Feb 28, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Nov 30, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Feb 28, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Nov 30, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| May 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Feb 29, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
| Company Name | Employees |
|---|---|
| Fresenius SE & Co. KGaA | 176,486 |
| Bayer Aktiengesellschaft | 91,864 |
| Siemens Healthineers AG | 73,840 |
| Merck KGaA | 59,020 |
| MEDICLIN Aktiengesellschaft | 10,472 |
| Stratec SE | 1,387 |
| Medios AG | 999 |
| FamiCord AG | 771 |
Heidelberg Pharma AG News
- 2 months ago - EQS-News: Heidelberg Pharma Announces Changes to the Executive Management Board – Dr Dongzhou Jeffery Liu Appointed as Chairman of the Executive Board and Chief Executive Officer - Wallstreet:Online
- 2 months ago - EQS-Adhoc: Heidelberg Pharma Announces Changes to the Executive Management Board - Dr Dongzhou Jeffery Liu Appointed as Chairman of the Executive Board and Chief Executive Officer - Wallstreet:Online
- 2 months ago - EQS-News: Heidelberg Pharma’s Lead ATAC Candidate HDP-101 Shows Progress in Phase I/IIa Trial in Multiple Myeloma - Wallstreet:Online
- 2 months ago - EQS-News: Heidelberg Pharma to Present New Clinical Data of Lead ADC Candidate HDP-101 at the World ADC Congress 2025 and to Host Webinar - Wallstreet:Online
- 3 months ago - EQS-NVR: Heidelberg Pharma AG: Release according to Article 41 of the WpHG [the German Securities Trading Act] with the objective of Europe-wide distribution - Wallstreet:Online
- 3 months ago - Heidelberg Pharma's Bold Moves in 2025's First 9 Months - Wallstreet:Online
- 3 months ago - EQS-News: Heidelberg Pharma Reports on the First Nine Months of Financial Year 2025 - Wallstreet:Online
- 3 months ago - Heidelberg Pharma AG Boosts Outlook: Exciting New Guidance Revealed! - Wallstreet:Online